ArticleJournal of psychiatry & neuroscience : JPN
The
Abstract readEditorial
In one paragraph
Article in Journal of psychiatry & neuroscience : JPN. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pharmacokinetics of oral Δ9-tetrahydrocannabinol (THC) administration in vervet monkeys.Journal of cannabis research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Patricia Di CianoFrom the Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ont. (Di Ciano, Wickens, Paul, Rueda); the Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ont. (Di Ciano, Wickens, Boileau); the Dalla Lana School of Public Health, University of Toronto, Toronto, Ont. (Di Ciano, Wickens, Crépault); the Campbell Family Mental Health Research Institute, Toronto, Ont. (Di Ciano, Wickens, Rueda, Boileau); the Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ont. (Rueda); the Department of Psychiatry, University of Toronto, Toronto, Ont. (Wickens, Boileau); the Institute of Medical Science, University of Toronto, Toronto, Ont. (Mahmood, Rueda, Boileau); the Addiction Imaging Research Group, Centre for Addiction and Mental Health, Toronto, Ont. (Mahmood, Boileau); the Brain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ont. (Boileau); Communications and Partnerships, Centre for Addiction and Mental Health, Toronto, Ont. (Crépault).
Christine WickensFrom the Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ont. (Di Ciano, Wickens, Paul, Rueda); the Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ont. (Di Ciano, Wickens, Boileau); the Dalla Lana School of Public Health, University of Toronto, Toronto, Ont. (Di Ciano, Wickens, Crépault); the Campbell Family Mental Health Research Institute, Toronto, Ont. (Di Ciano, Wickens, Rueda, Boileau); the Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ont. (Rueda); the Department of Psychiatry, University of Toronto, Toronto, Ont. (Wickens, Boileau); the Institute of Medical Science, University of Toronto, Toronto, Ont. (Mahmood, Rueda, Boileau); the Addiction Imaging Research Group, Centre for Addiction and Mental Health, Toronto, Ont. (Mahmood, Boileau); the Brain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ont. (Boileau); Communications and Partnerships, Centre for Addiction and Mental Health, Toronto, Ont. (Crépault).
Elvin M PaulFrom the Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ont. (Di Ciano, Wickens, Paul, Rueda); the Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ont. (Di Ciano, Wickens, Boileau); the Dalla Lana School of Public Health, University of Toronto, Toronto, Ont. (Di Ciano, Wickens, Crépault); the Campbell Family Mental Health Research Institute, Toronto, Ont. (Di Ciano, Wickens, Rueda, Boileau); the Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ont. (Rueda); the Department of Psychiatry, University of Toronto, Toronto, Ont. (Wickens, Boileau); the Institute of Medical Science, University of Toronto, Toronto, Ont. (Mahmood, Rueda, Boileau); the Addiction Imaging Research Group, Centre for Addiction and Mental Health, Toronto, Ont. (Mahmood, Boileau); the Brain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ont. (Boileau); Communications and Partnerships, Centre for Addiction and Mental Health, Toronto, Ont. (Crépault).
Raesham MahmoodFrom the Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ont. (Di Ciano, Wickens, Paul, Rueda); the Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ont. (Di Ciano, Wickens, Boileau); the Dalla Lana School of Public Health, University of Toronto, Toronto, Ont. (Di Ciano, Wickens, Crépault); the Campbell Family Mental Health Research Institute, Toronto, Ont. (Di Ciano, Wickens, Rueda, Boileau); the Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ont. (Rueda); the Department of Psychiatry, University of Toronto, Toronto, Ont. (Wickens, Boileau); the Institute of Medical Science, University of Toronto, Toronto, Ont. (Mahmood, Rueda, Boileau); the Addiction Imaging Research Group, Centre for Addiction and Mental Health, Toronto, Ont. (Mahmood, Boileau); the Brain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ont. (Boileau); Communications and Partnerships, Centre for Addiction and Mental Health, Toronto, Ont. (Crépault).
Jean-François CrépaultFrom the Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ont. (Di Ciano, Wickens, Paul, Rueda); the Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ont. (Di Ciano, Wickens, Boileau); the Dalla Lana School of Public Health, University of Toronto, Toronto, Ont. (Di Ciano, Wickens, Crépault); the Campbell Family Mental Health Research Institute, Toronto, Ont. (Di Ciano, Wickens, Rueda, Boileau); the Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ont. (Rueda); the Department of Psychiatry, University of Toronto, Toronto, Ont. (Wickens, Boileau); the Institute of Medical Science, University of Toronto, Toronto, Ont. (Mahmood, Rueda, Boileau); the Addiction Imaging Research Group, Centre for Addiction and Mental Health, Toronto, Ont. (Mahmood, Boileau); the Brain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ont. (Boileau); Communications and Partnerships, Centre for Addiction and Mental Health, Toronto, Ont. (Crépault).
Sergio RuedaFrom the Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ont. (Di Ciano, Wickens, Paul, Rueda); the Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ont. (Di Ciano, Wickens, Boileau); the Dalla Lana School of Public Health, University of Toronto, Toronto, Ont. (Di Ciano, Wickens, Crépault); the Campbell Family Mental Health Research Institute, Toronto, Ont. (Di Ciano, Wickens, Rueda, Boileau); the Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ont. (Rueda); the Department of Psychiatry, University of Toronto, Toronto, Ont. (Wickens, Boileau); the Institute of Medical Science, University of Toronto, Toronto, Ont. (Mahmood, Rueda, Boileau); the Addiction Imaging Research Group, Centre for Addiction and Mental Health, Toronto, Ont. (Mahmood, Boileau); the Brain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ont. (Boileau); Communications and Partnerships, Centre for Addiction and Mental Health, Toronto, Ont. (Crépault).
Isabelle BoileauFrom the Institute for Mental Health Policy Research, Centre for Addiction and Mental Health, Toronto, Ont. (Di Ciano, Wickens, Paul, Rueda); the Department of Pharmacology and Toxicology, University of Toronto, Toronto, Ont. (Di Ciano, Wickens, Boileau); the Dalla Lana School of Public Health, University of Toronto, Toronto, Ont. (Di Ciano, Wickens, Crépault); the Campbell Family Mental Health Research Institute, Toronto, Ont. (Di Ciano, Wickens, Rueda, Boileau); the Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ont. (Rueda); the Department of Psychiatry, University of Toronto, Toronto, Ont. (Wickens, Boileau); the Institute of Medical Science, University of Toronto, Toronto, Ont. (Mahmood, Rueda, Boileau); the Addiction Imaging Research Group, Centre for Addiction and Mental Health, Toronto, Ont. (Mahmood, Boileau); the Brain Health Imaging Centre, Centre for Addiction and Mental Health, Toronto, Ont. (Boileau); Communications and Partnerships, Centre for Addiction and Mental Health, Toronto, Ont. (Crépault) isabelle.boileau@camh.ca.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
CannabisHuman ExperimentationHumansLegislation, DrugMedical MarijuanaUnited StatesMedical Marijuana
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.